Skip to main content
Clinical Trials/NCT03104179
NCT03104179
Unknown
Not Applicable

Removal of Cytokines in Patients Undergoing Cardiac Surgery With CPB (The REMOTE Study)

Klinikum Nürnberg1 site in 1 country80 target enrollmentMay 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Extracorporeal Circulation
Sponsor
Klinikum Nürnberg
Enrollment
80
Locations
1
Primary Endpoint
Cytokine levels following CPB
Last Updated
9 years ago

Overview

Brief Summary

In a lot of cases during cardiac surgery cardiopulmonary bypass initiates SIRS due to release of cytokines during immunological response.

They are induced by different types of inductors ( intrinsic and extrinsic). High levels of inflammation markers like TNF-a, IL 6 and IL 10 as well as TGF-ß are detectable after 2 hours of surgery.

Beside the inflammation acute phase parameters like fibrinogen, ferritin are increased. These changes lead to rheology impairments.

These strong reactions lead to dysfunction of different organs possibly culminating in a multi organ failure.

There is a correlation between amounts of cytokines and mortality. Often AKI occurs after CPB with a rate of about 30%. Dysfunctions of organ function are often connected with increased mortality, prolonged mechanical ventilation , septic complications, increased catecholamine dosages and prolonged length of ICU stay.

Use of cytokine adsorption within the extracorporeal circuit during CBP can affect the circulating cytokine levels during and after CPB and lead to a diminished inflammatory response, acute phase reaction as well as reduction of organ failure.

Detailed Description

In a lot of cases during cardiac surgery cardiopulmonary bypass initiates SIRS due to release of cytokines during immunological response. They are induced by different types of inductors ( intrinsic and extrinsic). High levels of inflammation markers like TNF-a, IL 6 and IL 10 as well as TGF-ß are detectable after 2 hours of surgery. Beside the inflammation acute phase parameters like fibrinogen, ferritin are increased. These changes lead to rheology impairments. These strong reactions lead to dysfunction of different organs possibly culminating in a multi organ failure. There is a correlation between amounts of cytokines and mortality. Often AKI occurs after CPB with a rate of about 30%. Dysfunctions of organ function are often connected with increased mortality, prolonged mechanical ventilation , septic complications, increased catecholamine dosages and prolonged length of ICU stay. Use of cytokine adsorption within the extracorporeal circuit during CBP can affect the circulating cytokine levels during and after CPB and lead to a diminished inflammatory response, acute phase reaction as well as reduction of organ failure. Official Title: Removal of Cytokines in patients undergoing cardiac surgery with CPB ( The REMOTE Study) Study type: Interventional Study design: randomized, controlled Endpoint Classification: Efficacy study Interventional Model: Parallel assignment Masking: Single blinding ( Subject) Primary purpose: Treatment Patients who have an elective cardiac surgery with an expected CPB duration \> 75 min ( e.g. valve surgery, CABG, combined procedures, redo) will be enrolled into the study after a giving informed consent. Selection of patients are directed by randomization. Patient which drop out will be replaced.

Registry
clinicaltrials.gov
Start Date
May 2017
End Date
May 2019
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

PD Dr. med. Giuseppe Santarpino

PD, Dr. med

Klinikum Nürnberg

Eligibility Criteria

Inclusion Criteria

  • Elective cardiac surgery with CPB
  • Signed informed consent
  • CPB time \> 75 min.
  • Comorbidities:
  • diabetes mellitus
  • CHF, NYHA class 1 and 2
  • liver dysfunction (1, 2)
  • kidney dysfunction (1, 2)
  • hypertension
  • arteriosclerosis

Exclusion Criteria

  • Age \< 65 years
  • Declined informed consent
  • Planed temperature \< 32 C
  • Emergency surgery
  • Preexisting renal replacement therapy
  • Preexisting kidney transplantation
  • Administration of immunosuppressants like steroids
  • AIDS with CD 4 \< 200/
  • Participation in other trials

Outcomes

Primary Outcomes

Cytokine levels following CPB

Time Frame: 72 hours

Evaluation of cytokine adsorber effect on cytokine levels intra- and post

Secondary Outcomes

  • Level of haptoglobin(72 hours)
  • Intra- and postoperative catecholamine dosages(until ICU discharge, expected average 4 days)
  • Level of transferrin(72 hours)
  • postoperative renal failure necessitating RRT(until ICU discharge, expected average 4 days)
  • Level of ferritin(72 hours)
  • Length of ICU stay(until discharge from ICU, expected average 4 days)
  • Length of hospital stay(up to hospital discharge, expected average 14 days)

Study Sites (1)

Loading locations...

Similar Trials